Group One Trading
DICE

Group One Trading’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Group One Trading’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,200
Closed -$288K – 8620
2023
Q2 		$288K Buy
6,200
+4,400
+244% +$152K ﹤0.01% 3584
2023
Q1 		$51.6K Buy
1,800
+1,200
+200% +$35.5K ﹤0.01% 4823
2022
Q4 		$18.7K Sell
600
-30,700
-98% -$1M ﹤0.01% 5636
2022
Q3 		$635K Buy
+31,300
New +$570K ﹤0.01% 3000

Group One Trading's DICE Position: Q2 2023 in Review

Group One Trading sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 5,399 shares — an estimated $187K sold.

Group One Trading first reported a position in DICE in Q3 2022 and held it in 2 quarters. The position peaked at $281K in Q3 2022. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

  • Group One Trading reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 5,399 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $187K.
  • Group One Trading first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Group One Trading's DICE Therapeutics, Inc. Common Stock position peaked at $281K in Q3 2022.
  • 160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.